FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038346039> ?p ?o ?g. }

• W2038346039 abstract "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CACirculating microRNAs are promising candidates as minimally-invasive biomarkers for tumor detection, disease monitoring, and patient stratification. Increases in serum concentrations have been reported for many microRNAs up-regulated in tumor cells. However, how well global changes in tumor microRNA expression are reflected in circulating microRNAs is less understood.To answer this question, we performed experiments in a Tet-regulated mouse HRAS model of hepatocellular carcinoma (HCC). Male mice develop detectable HCC within a few weeks from activation of the oncogenic HRAS allele. Matched serum and liver tissues for microRNA profiling were collected at three timepoints: right before HRAS activation (normal liver), 3 weeks after activation (moderate tumor burden), and 6 weeks after activation (pervasive tumors). To emulate the effect of targeted treatment, we inactivated the HRAS allele in a group of animals 3 weeks after activation and collected serum and liver tissues at the 6 weeks timepoint (3 weeks HRAS on, 3 weeks off). Global liver and serum microRNA profiles were measured using the OpenArray TaqMan qPCR Platform.The global microRNA profiling analysis revealed that the overall number of detected serum microRNAs as well as the overall serum expression increased with tumor progression and normalized after the HRAS withdrawal. In the liver, 3 weeks after the HRAS activation we observed small changes with just 7 differentially expressed microRNAs at FDR < 20%. The changes became much more pronounced at 6 weeks with 89 microRNAs passing the FDR < 20% threshold. Most of these changes reversed in the 3 weeks on/3 weeks off group and these samples resembled the normal liver controls. Many microRNAs differentially expressed in the liver were also altered in serum, albeit with smaller average fold changes in serum compared to liver. The fold changes were positively correlated between liver and serum samples (Pearson R = 0.25, p < 0.01). We detected additional significant changes in serum microRNAs not reflected in liver tissues samples. The serum-specific alteration included microRNAs linked to immune response, liver injury and other systemic responses to the tumor burden. Similarly to liver, the serum changes were most pronounced in the 6 weeks HRAS group and partially reverted to normal-like profiles in the 3 weeks on/3 weeks off group.In conclusion, using a mouse model of HCC we found that (1) deregulation of liver microRNA profiles increases with the tumor size and (2) that serum microRNA profiles reflect both changes in the tumor tissues and well systemic response to tumor burden. Importantly, most of the changes in both liver and serum are reversed upon inhibition of the driving oncogene. Thus circulating microRNAs are promising candidates for tumor detection, disease monitoring, and monitoring of treatment response.Citation Format: Adam Pavlicek, Vladyslava Ratushna, Shirley Phillips, Cynthia Heinlein, Jian Li, Vivek Kaimal, Sonya Zabludoff, Nelson Chau. Serum microRNAs reflect microRNA expression in tumor tissues as well as systemic response to disease in HRAS-driven mouse models of HCC. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 5234. doi:10.1158/1538-7445.AM2014-5234" @default.
• W2038346039 created "2016-06-24" @default.
• W2038346039 creator A5007014098 @default.
• W2038346039 creator A5014104477 @default.
• W2038346039 creator A5052883326 @default.
• W2038346039 creator A5054301218 @default.
• W2038346039 creator A5055212394 @default.
• W2038346039 creator A5063576692 @default.
• W2038346039 creator A5066906175 @default.
• W2038346039 creator A5088537785 @default.
• W2038346039 date "2014-09-30" @default.
• W2038346039 modified "2023-10-16" @default.
• W2038346039 title "Abstract 5234: Serum microRNAs reflect microRNA expression in tumor tissues as well as systemic response to disease in HRAS-driven mouse models of HCC" @default.
• W2038346039 doi "https://doi.org/10.1158/1538-7445.am2014-5234" @default.
• W2038346039 hasPublicationYear "2014" @default.
• W2038346039 type Work @default.
• W2038346039 sameAs 2038346039 @default.
• W2038346039 citedByCount "0" @default.
• W2038346039 crossrefType "proceedings-article" @default.
• W2038346039 hasAuthorship W2038346039A5007014098 @default.
• W2038346039 hasAuthorship W2038346039A5014104477 @default.
• W2038346039 hasAuthorship W2038346039A5052883326 @default.
• W2038346039 hasAuthorship W2038346039A5054301218 @default.
• W2038346039 hasAuthorship W2038346039A5055212394 @default.
• W2038346039 hasAuthorship W2038346039A5063576692 @default.
• W2038346039 hasAuthorship W2038346039A5066906175 @default.
• W2038346039 hasAuthorship W2038346039A5088537785 @default.
• W2038346039 hasConcept C104317684 @default.
• W2038346039 hasConcept C1167327 @default.
• W2038346039 hasConcept C121608353 @default.
• W2038346039 hasConcept C126322002 @default.
• W2038346039 hasConcept C143660080 @default.
• W2038346039 hasConcept C145059251 @default.
• W2038346039 hasConcept C203014093 @default.
• W2038346039 hasConcept C2776964913 @default.
• W2038346039 hasConcept C2778019345 @default.
• W2038346039 hasConcept C2781187634 @default.
• W2038346039 hasConcept C48023723 @default.
• W2038346039 hasConcept C502942594 @default.
• W2038346039 hasConcept C526805850 @default.
• W2038346039 hasConcept C54355233 @default.
• W2038346039 hasConcept C71924100 @default.
• W2038346039 hasConcept C86803240 @default.
• W2038346039 hasConceptScore W2038346039C104317684 @default.
• W2038346039 hasConceptScore W2038346039C1167327 @default.
• W2038346039 hasConceptScore W2038346039C121608353 @default.
• W2038346039 hasConceptScore W2038346039C126322002 @default.
• W2038346039 hasConceptScore W2038346039C143660080 @default.
• W2038346039 hasConceptScore W2038346039C145059251 @default.
• W2038346039 hasConceptScore W2038346039C203014093 @default.
• W2038346039 hasConceptScore W2038346039C2776964913 @default.
• W2038346039 hasConceptScore W2038346039C2778019345 @default.
• W2038346039 hasConceptScore W2038346039C2781187634 @default.
• W2038346039 hasConceptScore W2038346039C48023723 @default.
• W2038346039 hasConceptScore W2038346039C502942594 @default.
• W2038346039 hasConceptScore W2038346039C526805850 @default.
• W2038346039 hasConceptScore W2038346039C54355233 @default.
• W2038346039 hasConceptScore W2038346039C71924100 @default.
• W2038346039 hasConceptScore W2038346039C86803240 @default.
• W2038346039 hasLocation W20383460391 @default.
• W2038346039 hasOpenAccess W2038346039 @default.
• W2038346039 hasPrimaryLocation W20383460391 @default.
• W2038346039 hasRelatedWork W1500924297 @default.
• W2038346039 hasRelatedWork W1655320359 @default.
• W2038346039 hasRelatedWork W2007326349 @default.
• W2038346039 hasRelatedWork W2024695589 @default.
• W2038346039 hasRelatedWork W2028831638 @default.
• W2038346039 hasRelatedWork W2144146560 @default.
• W2038346039 hasRelatedWork W2409180880 @default.
• W2038346039 hasRelatedWork W2415924001 @default.
• W2038346039 hasRelatedWork W2421814103 @default.
• W2038346039 hasRelatedWork W2574514322 @default.
• W2038346039 hasRelatedWork W2579335743 @default.
• W2038346039 hasRelatedWork W2895560116 @default.
• W2038346039 hasRelatedWork W2963038563 @default.
• W2038346039 hasRelatedWork W2982558798 @default.
• W2038346039 hasRelatedWork W2994826478 @default.
• W2038346039 hasRelatedWork W3008714871 @default.
• W2038346039 hasRelatedWork W3028617746 @default.
• W2038346039 hasRelatedWork W3029120832 @default.
• W2038346039 hasRelatedWork W3110738097 @default.
• W2038346039 hasRelatedWork W3159823480 @default.
• W2038346039 isParatext "false" @default.
• W2038346039 isRetracted "false" @default.
• W2038346039 magId "2038346039" @default.
• W2038346039 workType "article" @default.